SCHEMBL1675157

SCHEMBL1675157

c1nc(NCCc2c[nH]cn2)c2cc(-c3ccoc3)ccc2n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 19/20 0.62
USP2 O75604 15/20 0.62
CYP1A2 P05177 15/20 0.62
ALDH1A1 P00352 14/20 0.62
HSD17B10 Q99714 12/20 0.62
MEN1 O00255 9/20 0.62
KMT2A Q03164 9/20 0.62
CASP1 P29466 1/20 0.62
CYP2D6 P10635 13/20 0.61
CYP3A4 P08684 12/20 0.61
CYP2C19 P33261 9/20 0.58
LMNA P02545 8/20 0.58
HIF1A Q16665 7/20 0.58
CYP2C9 P11712 3/20 0.58
TP53 P04637 1/20 0.58
RECQL P46063 1/20 0.58
CLK1 P49759 4/20 0.58
DYRK1A Q13627 2/20 0.58
TSHR P16473 7/20 0.56
MAPK1 P28482 4/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675205 0.82 CLK4 (0.68) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675238 0.81 CLK1 (0.58) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675360 0.80 CLK4 (0.57) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675270 0.79 CLK4 (0.60) CLK4USP2CYP1A2MEN1KMT2A
SCHEMBL1675044 0.79 CLK4 (0.51) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675090 0.77 CLK1 (0.41) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675497 0.77 CLK4 (0.45) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675093 0.77 CLK4 (0.61) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675348 0.75 DYRK1A (0.43) CLK4USP2CYP1A2ALDH1A1HSD17B10
SCHEMBL1675314 0.74 CLK4 (0.44) CLK4USP2CYP1A2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed